Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)

Shattuck Labs - STTK Stock Forecast, Price & News

$2.19
-0.10 (-4.37%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.02
$2.32
50-Day Range
$1.96
$3.26
52-Week Range
$1.85
$9.61
Volume
76,379 shs
Average Volume
159,005 shs
Market Capitalization
$92.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.50

Shattuck Labs MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
744.7% Upside
$18.50 Price Target
Short Interest
Healthy
0.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.43) to ($2.20) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.52 out of 5 stars

Medical Sector

339th out of 1,040 stocks

Pharmaceutical Preparations Industry

153rd out of 509 stocks

STTK stock logo

About Shattuck Labs (NASDAQ:STTK) Stock

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Receive STTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shattuck Labs and its competitors with MarketBeat's FREE daily newsletter.

STTK Stock News Headlines

Preview: Shattuck Labs's Earnings
Recap: Shattuck Labs Q2 Earnings
Shattuck Labs, Inc. (STTK)
STTK, LYEL and MPWR among after hour movers
See More Headlines
Receive STTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shattuck Labs and its competitors with MarketBeat's FREE daily newsletter.

STTK Company Calendar

Last Earnings
11/09/2021
Today
11/28/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/21/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:STTK
Fax
N/A
Employees
85
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.50
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+744.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-44,970,000.00
Pretax Margin
-226.32%

Debt

Sales & Book Value

Annual Sales
$30.02 million
Book Value
$6.43 per share

Miscellaneous

Free Float
38,199,000
Market Cap
$92.84 million
Optionable
Not Optionable
Beta
0.95

Key Executives

  • Dr. Taylor H. Schreiber M.D.Dr. Taylor H. Schreiber M.D. (Age 42)
    Ph.D., Co-Founder, CEO & Director
    Comp: $744.45k
  • Dr. Arundathy Nirmalini Pandite M.B.A. (Age 63)
    M.D., Chief Medical Officer
    Comp: $638.44k
  • Ms. Casi DeYoung (Age 51)
    Chief Bus. Officer
    Comp: $523.48k
  • Mr. Andrew R. Neill M.B.A.Mr. Andrew R. Neill M.B.A. (Age 36)
    Chief Financial Officer
  • Conor Richardson
    Sr. Director of Fin. & Investor Relations
  • Dr. Abhinav A. Shukla Ph.D. (Age 49)
    Chief Technical Officer
  • Ms. Erin Ator Thomson J.D.Ms. Erin Ator Thomson J.D. (Age 42)
    Gen. Counsel, Corp. Sec. and Chief Ethics & Compliance Officer
  • Dr. Thomas Lampkin Pharm.D.
    Sr. VP of Regulatory Affairs
  • Ms. Fatima Rangwala M.D.
    Ph.D., Sr. VP of Clinical Research













STTK Stock - Frequently Asked Questions

Should I buy or sell Shattuck Labs stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Shattuck Labs in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STTK shares.
View STTK analyst ratings
or view top-rated stocks.

What is Shattuck Labs' stock price forecast for 2023?

4 Wall Street analysts have issued 1 year price objectives for Shattuck Labs' shares. Their STTK share price forecasts range from $12.00 to $28.00. On average, they expect the company's stock price to reach $18.50 in the next year. This suggests a possible upside of 744.7% from the stock's current price.
View analysts price targets for STTK
or view top-rated stocks among Wall Street analysts.

How have STTK shares performed in 2022?

Shattuck Labs' stock was trading at $8.51 on January 1st, 2022. Since then, STTK stock has decreased by 74.3% and is now trading at $2.19.
View the best growth stocks for 2022 here
.

When is Shattuck Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our STTK earnings forecast
.

How were Shattuck Labs' earnings last quarter?

Shattuck Labs, Inc. (NASDAQ:STTK) posted its earnings results on Tuesday, November, 9th. The company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.45) by $0.04. The firm had revenue of $1.90 million for the quarter.

When did Shattuck Labs IPO?

(STTK) raised $150 million in an initial public offering on Friday, October 9th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and Evercore ISI acted as the underwriters for the IPO and Needham & Co. was co-manager.

What is Shattuck Labs' stock symbol?

Shattuck Labs trades on the NASDAQ under the ticker symbol "STTK."

Who are Shattuck Labs' major shareholders?

Shattuck Labs' stock is owned by many different institutional and retail investors. Top institutional shareholders include Clark Estates Inc. NY (3.17%), Prosight Management LP (2.64%), BlackRock Inc. (1.78%), Renaissance Technologies LLC (0.63%), Investment Management of Virginia LLC (0.56%) and Benjamin F. Edwards & Company Inc. (0.40%). Insiders that own company stock include Andrew R Neill, Erin Ator Thomson, George Golumbeski, Josiah Hornblower, Redmile Group, Llc, Taylor Schreiber and Tyler Brous.
View institutional ownership trends
.

How do I buy shares of Shattuck Labs?

Shares of STTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Shattuck Labs' stock price today?

One share of STTK stock can currently be purchased for approximately $2.19.

How much money does Shattuck Labs make?

Shattuck Labs (NASDAQ:STTK) has a market capitalization of $92.84 million and generates $30.02 million in revenue each year. The company earns $-44,970,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis.

How can I contact Shattuck Labs?

The official website for the company is www.shattucklabs.com. The company can be reached via phone at 512-900-4690 or via email at investorrelations@shattucklabs.com.

This page (NASDAQ:STTK) was last updated on 11/28/2022 by MarketBeat.com Staff